RCT, Blinded, 2-Arm Efficacy Study of IP and Placebo in Patients With Chronic Pain Related to Osteoarthritis of the Knee
Phase 3
- Conditions
- Degenerative Arthritis
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-04-08
- Last Posted Date
- 2022-04-14
- Lead Sponsor
- Overseas Pharmaceuticals, Ltd.
- Target Recruit Count
- 500
- Registration Number
- NCT05318521
- Locations
- 🇺🇸
Palm Beach Research Center, West Palm Beach, Florida, United States
To Evaluate the Food Effect and the Absorption Profile of Ibuprofen Controlled-Release Tablets 600 mg in Comparison to the Reference Standard Ibuprofen Tablets in Normal Healthy Volunteers
Phase 1
Terminated
- Conditions
- Pain Control
- Interventions
- First Posted Date
- 2018-02-01
- Last Posted Date
- 2022-04-01
- Lead Sponsor
- Overseas Pharmaceuticals, Ltd.
- Target Recruit Count
- 31
- Registration Number
- NCT03418805
- Locations
- 🇨🇳
Tri-Service General Hospital, Taipei, Taiwan
© Copyright 2025. All Rights Reserved by MedPath